Target and Biomarker Exploration Portal for Drug Discovery
Authors:
Preprint
- 10 January 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
The discovery of novel drug targets and precision biomarkers remains a major challenge in drug development, with traditional differential expression analysis often overlooking key regulatory proteins. Here, we present a novel, web-based bioinformatics tool designed to accelerate the drug discovery process by integrating large-scale biomedical data with network analysis techniques. This tool harnesses machine-learning approaches to combine multi-modal datasets, including human genetics, functional genomics, and protein-protein interaction networks, to decode causal disease mechanisms and uncover novel therapeutic targets and precision biomarkers for specific phenotypes. A unique feature of the tool is its ability to process large-scale data in real-time, facilitated by efficient cloud-based architecture. Additionally, the tool incorporates an integrated large language model (LLM), which assists researchers in exploring and interpreting complex biological relationships within the generated networks and multi-omics data. By offering an intuitive, interactive interface, the LLM enhances the exploration of biological insights, making it easier for scientists to derive actionable conclusions. This powerful integration of AI-driven network analysis, multi-omics data, and advanced language models provides a robust framework for accelerating the identification of novel drug targets, ultimately advancing the field of precision medicine. The tool is publicly available at https://pdnet.missouri.edu/.Keywords
All Related Versions
This publication has 32 references indexed in Scilit:
- Web-based multi-omics integration using the Analyst software suiteNature Protocols, 2024
- Large language models encode clinical knowledgeNature, 2023
- DrugnomeAI is an ensemble machine-learning framework for predicting druggability of candidate drug targetsCommunications Biology, 2022
- Mendelian Randomization Study Using Dopaminergic Neuron‐Specific eQTL Nominates Potential Causal Genes for Parkinson's DiseaseMovement Disorders, 2022
- Tau in the Pathophysiology of Parkinson’s DiseaseJournal of Molecular Neuroscience, 2021
- α-Synuclein misfolding and aggregation: Implications in Parkinson’s disease pathogenesisBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2019
- Conserved cell types with divergent features in human versus mouse cortexNature, 2019
- Human whole genome genotype and transcriptome data for Alzheimer’s and other neurodegenerative diseasesScientific Data, 2016
- Analyzing and interpreting genome data at the network level with ConsensusPathDBNature Protocols, 2016
- The Genotype-Tissue Expression (GTEx) projectNature Genetics, 2013